baber/WOPTO huggingface dataset:
Patent NZ-318789-A (NZ)
Title: Mobile communication system and method for establishing a data call
Inventor: RASANEN JUHA
IPC: H04W28/22
Filed: 1996-09-25
Abstract: The present invention generally relates to data transmission services in mobile communication systems. A mobile subscriber may typically be entitled to different kinds of tele and bearer services. Presently, each user data rate is an independent bearer service. This means that there is a vast number of bearer services, which causes problems for both the network operators and the mobile subscribers. According to the invention, the number of bearer services is reduced by defining the bearer service to cover several data rates, and by negotiating, at the call set-up stage, the data rate to be used by the data call in the bearer service between the mobile station (MS) and the mobile communication network (MSC). The next step is to negotiate the data rate between the mobile communication network (MSC) and the fixed network, such as PSTN or ISDN. Then, if required, the data rate of the mobile communication network and the radio channel resources are adapted to the data rate used towards the fixed network.
Patent NZ-333812-A (NZ)
Title: Tetrahydroquinoline derivatives as excitatory amino acid (EAA) antagonists useful for neurodegenerative diseases
Inventor: DI-FABIO ROMANO
IPC: C07D215/48
Filed: 1997-08-14
Abstract: Compounds of formula described or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO2R2 or COR2 wherein R2 represents hydroxy, methoxy, amino, alkylamino or dialkylamino; m is zero or an integer 1 or 2; R1 represents a group (CH2)nCN, -CH=CHR3, (CH2)nNHCOCH2R4 or O(CH2)pNR5R6; R3 represents cyano or the group COR7; R4 represents alkoxy or a group NHCOR8; R5 and R6 each represent independently hydrogen or alkyl, or R5 and R6 together with the nitrogen atom to which they are attached represent a heterocyclic group, or R5 is hydrogen and R6 is the group COR9; R7 represents an alkoxy, amino or hydroxyl group; R8 represents a hydrogen atom or optionally substituted alkyl, alkoxy, aryl or heterocyclic group; R9 is the group R8 or the group NR10R11 wherein R10 represents hydrogen or alkyl group; R11 represents optionally substituted alkyl, aryl, heterocyclic or cycloalkyl group; n is zero or an integer from 1 to 4; p is an integer from 2 to 4. The compound described is useful for the preparation of medicaments that antagonised the effects of excitatory amino acids upon NMDA receptor complex.
Patent NZ-334562-A (NZ)
Title: Plastic bag with a reclosable zipper having two profile strips, each strip having at least one elongate flange and an elongate seal means with the seal means sealed to each other at their ends immediately inwardly of the side regions of the bag
Inventor: OLSEN LAWRENCE JOSEPH
IPC: B31B23/00
Filed: 1999-03-09
Abstract: A method of driving a film formed into a tube about a vertical forming tube (48) of a vertical form, fill and seal machine, along said vertical forming tube (48).  The film carries, at regular bag length intervals, a reclosable zip (6) extending transversely about a semicircle of the tube (48) having distal end portions located substantially diametrically opposite each other.  The driving means comprises two endless flexible members (49) positioned adjacent to the tube and diametrically opposite, wherein the film is engaged therebetween and driven downwards.  The flexible members (49) have a recess to accommodate the different thickness of the film material provided by the reclosable zip.
Patent NZ-337195-A (NZ)
Title: Epothilones with a modified side chain
Inventor: HOFLE GERHARD
IPC: C07D493/04
Filed: 1998-02-25
Abstract: Process for the preparation of epothilones that are modified in the side chain, wherein: 1. for the preparation of epothilones which are modified in the 16, 17-position the starting materials are 3,7-protected or unprotected epothilones A or B and a. hydrogenation on the 16, 17-double bond or b. an addition reaction with halogen on the 16,17 double bond or c. epoxidation on the 16,17-double bond and, if appropriate, the resulting epoxide is   reduced to give the 16-alcohol; or 2. for the preparation of 2,3-unsaturated epothilone N oxides either a. 3,7-protected epothilones A or B are converted into an N oxide in a manner known per se and, the 3-substituent is eliminated by a base to give the 2,3-double bond, or b. 7-protected or 7-unprotected epothilones A or B which have a double bond in the 2,3-position are converted into an N-oxide in a manner known per se; or 3. for the preparation of epothilone N-oxides 3,7protected or unprotected epothilones A or B are converted into an N-oxide in a manner known per se; or 4. for the preparation of epothilones which are modified in the C19-position 3,7-protected or unprotected epothilones A or B are metalated in the C19-position and captured with electrophilic reagents in a manner known per se as alkyl-, aryl-, heteroaryl-, halogen-, oxygen- or sulphur-substituted epothilones which are modified in the C19-position; or 5. for the preparation of epothilones that are modified in the C27-position the allyl group (C17, C16 and C27) is substituted in a manner known per se on the C27-methyl group by a hetero atom. N-oxide epothilones of formulae (I) and (II) can be made by this method, wherein for formula (I), R, R1 and R2 are hydrogen, Z is O- and for formula (II), R1 and R2 are hydrogen, Z is O- and R is methyl.
Patent NZ-337350-A (NZ)
Title: Body implantable device comprising a reservoir and gas generating means for the delivery of progesterone
Inventor: BUNT CRAIG ROBERT
IPC: A61D7/00
Filed: 1997-04-03
Abstract: Described is a substance delivery intra vaginal device for delivering progesterone.  The device has a resilient elongate body, a sealed chamber which contains a bladder.  The bladder is able to deliver progesterone when an external gas pressure is applied from within the chamber to the bladder.  The bladder has a volume of at least 5mls.  The gas pressure is applied via a battery/electrode system.
Patent NZ-503879-A (NZ)
Title: Polymeric derivatives of camptothecins
Inventor: ZAMAI MORENO
IPC: A61K47/48
Filed: 1998-09-22
Abstract: A polymeric conjugate that consists of: a) from 85 to 97 mol % of N-(2-hydroxypropyl)methacryloylamide units of formula 3; b) from 3 to 15 mol % of 20-O-(N-methacryloyl-glycy-laminoacyl-glycyl)-camptothecin units of formula 4, wherein n is from 2 to 8, -[O-CPT] represents the residue of a camptothecin of formula 2, which is linked at the C-20 position and in which each of R1, R2, R3, R4 and R5, which are the same or different is H, C1-C12 linear or branched alkyl, nitro, amino, (CH2)aNR6R7 in which a is from 0 to 4 and R6 and R7 are H or one of R6 or R7 is H and the other R6 or R7 is C1-C6alkyl, or NR6R7 represents a piperazino or N-alkyl-piperazino ring optionally substituted with C1-C6 linear or branched alkyl, or a piperidino ring, (CH2)aNHCOR8 in which a is as defined previously and R8 is C1-C8 linear or branched alkyl or a group NR6R7 as above, hydroxy or O-CO-R8 in which R8 is as above defined or represents a 1-piperidino ring or 1,4'-bipiperidine, or R2 and R3 taken together represent a residue O-(CH2)b-O, in which b is 1 or 2, or R4 and R5 represents the residue (CH2)m in which m is from 2 to 4, or the residue CH2-O-CH2 or CH2NHCH2 ; and c) from 0 to 12 mol % of N-methylacryloyl-glycine or N-(2-hydroxy-propyl)methacryloyl-glycinamide units of formula 5, wherein [Z] is hydroxy or a residue of the formula -NH-CH2-CH(OH)-CH3. The conjugates can be used as anti-tumor agents.
Patent NZ-507628-A (NZ)
Title: Method of removing the colour from a dairy material by bleaching
Inventor: BRODY ERNEST P
IPC: A23L5/49
Filed: 2000-02-17
Abstract: A method of producing a reduced colour dairy product that includes separating a dairy material into a first portion and a second portion, the first portion including at least about 30 weight percent, as determined by high pressure liquid chromatography at a detection wavelength of 280 nanometers, of the native and soluble protein from the dairy material and the second portion including at least about 50 weight percent of the colouring agent from the dairy material, and partially or fully deactivating at least some of the colouring agent present in the second portion.
Patent NZ-508734-A (NZ)
Title: A method for producing cloned cows
Inventor: LIM JEONG-MUK
IPC: C12N15/00
Filed: 2000-06-30
Abstract: A method for producing cloned cows: (i) preparing donor somatic cell lines collected from cow, (ii) maturing oocytes collected from ovary (iii)removing cumulus cells surrounding the oocytes, cutting a portion of zona pellucida of the matured oocytes to make a slit, squeezing out a portion of cytoplasm including the first polar body through the slit to give enucleated recipient oocytes, (iv) transferring a nucleus to the recipient oocyte by injection of the donor cells to the enucleated recipient oocyte, followed by subsequent electrofusion and activation of the electrofused cells to give embryos (v) postactivating and culturing the embryos in vitro (vi) transferring the cultured embryos intro surrogate cows to produce cloned calves.
Patent NZ-514469-A (NZ)
Title: Chemical synthesis of cohalogenated compounds
Inventor: MANLEY-HARRIS MERILYN
IPC: C12P33/00
Filed: 2001-09-26
Abstract: A method of producing a co-halogenated carbon based compound by adding halogen(s) and hydroxyl group(s) to a multiple bond in an initial carbon based compound, the method characterised by the step of (a) reacting the initial compound with a primary reagent in the presence of a catalyst, wherein the primary reagent reacts with the multiple bond to produce the cohalogenated compound and wherein the catalyst is a reducing agent.
Patent NZ-515810-A (NZ)
Title: Steroid derivatives
Inventor: LIAO SHUTSUNG
IPC: A61P25/28
Filed: 2000-04-27
Abstract: Steroid derivatives are disclosed that interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders.
Patent NZ-516192-A (NZ)
Title: Method for manufacturing a binder and use thereof
Inventor: PERANDER MICHAEL
IPC: D04H1/64
Filed: 2000-06-20
Abstract: A method for making a fire resistant binder, wherein  a particulate mineral wool material having a glassy  amorphous structure  is  dissolved in an aqueous solution  to  form  a solution  containing  nucleated  re-precipitated  particles, and  then  stabilizing the solution to form  a  sol  of  the binder  solution.  The binder solution can then be contacted with mineral wool fibres to form a mineral wool product.
Patent NZ-516209-A (NZ)
Title: Indoloazepines as vasopressin receptor antagonists
Inventor: HOEKSTRA WILLIAM J
IPC: A61P9/12
Filed: 2000-06-15
Abstract: A compound of formula (1) and the use thereof in treating conditions mediated by a vasopressin receptor.
Patent NZ-516386-A (NZ)
Title: Solid-liquid extraction of high molecular weight primary aliphatic alcohols from beeswax and pharmaceutical use thereof
Inventor: PEREZ PEDRO P
IPC: A61P25/28
Filed: 2000-06-20
Abstract: A naturally obtained mixture of higher molecular weight primary aliphatic alcohols that contain 24 to 34 carbon atoms and a process for obtaining the alcohol mixture by extraction and purification with organic solvents from beeswax without saponification of the beeswax is disclosed, The alcohol mixture obtained from beeswax has enhanced purity and contains a mixture of alcohols having 24, 26, 27, 28, 29, 30, 32 and 34 carbon atoms. The alcohol mixture is useful in pharmaceutical compositions, foodstuffs and dietary supplements and is effective for lowering cholesterol in LDL-C levels so that it is effective in treating hypercholesterolemia. Consequently the composition may be used to reduce the risk of coronary heart disease, the atherosclerotic process (platelet hyperaggregability, ischemia and thrombosis) and also acts as an anti-inflammatory and anti-thrombotic agent. The composition also possesses neurotrophic properties and is useful for preventing neurodegenerative disorders.
Patent NZ-529187-A (NZ)
Title: Composition for treating drug-induced constipation with 15-keto-prostaglandins
Inventor: UENO RYUJI
IPC: A61K31/557
Filed: 2002-04-26
Abstract: Disclosed is the use of a 15-keto compound represented by the formula (II): wherein L and M are hydrogen, hydroxy, halogen, lower alkyl, hydroxy(lower)alkyl or oxo, wherein at least one of L and M is a group other than hydrogen, and the five-membered ring may have at least one double bond; A is -COCH2OH, -COOH or a functional derivative thereof; B is -CH2-CH2-, -CH=CH-, -CC-; X1 and X2 are H, (lower) alkyl, or halogen provided that at least one of X1 and X2 is halogen; R1 is a saturated or unsaturated bivalent lower or medium aliphatic hydrocarbon residue, which is unsubstituted or substituted with halogen, alkyl, hydroxy, oxo, aryl or heterocyclic group and at least one of carbon atom in the aliphatic hydrocarbon is optionally substituted by oxygen, nitrogen or sulfur; R2 is a single bond or lower alkylene; and R3 is lower alkyl, lower alkoxy, cyclo(lower)alkyl, cyclo(lower)alky aryl, aryloxy, heterocyclic group or heterocyclic-oxy group, for manufacturing a pharmaceutical composition for treating drug-induced constipation.
Patent NZ-530697-A (NZ)
Title: Coloured paint for the screen printing of the inner side of insert-moulding pieces
Inventor: NUMRICH UWE
IPC: C08J7/06
Filed: 2002-08-13
Abstract: A coloured paint, suitable for the printing of films made from transparent, thermoplastic plastics, essentially comprising: a) one or more pigments, b) a binding agent, dissolved in c) an organic solvent or a mixture of organic solvents and d) usual adjuncts, characterised in that a poly(meth)acrylate or a poly(meth)acrylimide compound is used as binding agent with a vicat softening temperature VET (ISO 306 B) of at least 115 DEG C. The invention further relates to printed films and insert-moulding pieces, produced using the above paint and the corresponding method for production and uses of the said insert-moulding pieces.
Patent NZ-531555-A (NZ)
Title: Dispenser wall bracket
Inventor: HUBMANN CURTIS HANS
IPC: B67D7/02
Filed: 2002-09-10
Abstract: A dispensing assembly wall bracket for mounting an operable dispensing assembly to an essentially vertical surface is disclosed. The bracket includes a base fixable to the vertical surface, and defining a plane which is substantially parallel to the vertical surface when the base is fixed thereto. A fitting is fixed to the base, and has an inlet and an outlet. The inlet defines an axis substantially parallel to the plane, and the outlet defines an axis which intersects the inlet axis. At least one support arm extends from the base, and has a proximal end fixed to the base and a distal end. A receptacle is supported by the support arm distal end, and aligned with the outlet axis, wherein a dispensing assembly having an inlet received in the receptacle is positioned for connecting the dispensing assembly inlet to the fitting outlet.
Patent NZ-535478-A (NZ)
Title: Conveyorized oven with moisture laden air impingement and method
Inventor: JONES DOUGLAS S
IPC: A23L5/10
Filed: 2003-03-27
Abstract: Disclosed is a conveyor oven having a heating chamber (22) and an oven chamber (24). A conveyor (26) is disposed in the oven chamber to convey food products between an entry port and an exit port. An air impingement assembly is disposed to provide jets of impingement air toward the food product. A fan blower, a heater (74) and a moisture delivery device (75) are arranged to provide a heated and moisture laden airflow to the air impingement assembly, so that the jets of air are heated and laden with moisture and thereby produce a mixture of air and moisture at the surface of the food product.
Patent NZ-537713-A (NZ)
Title: Support part or bracket
Inventor: HOCKING RORY GARTH
IPC: B07C1/00
Filed: 2003-08-21
Abstract: A support part or bracket for supporting an item from an upright member, including a hollow interior defined between an upper portion for engaging the upright member from a rear and a lower portion for engaging the upright member from a front when the item is mounted to the upright member, and an entry in the form of a longitudinally extending aperture on one side of the support part, so that the item can be mounted to the upright member by tilting the support part upwardly from it's normal mounted position, moving the support part on to the upright member from one side so that the tubular upright member passes through the entry passage into the support part, and then tilting the item downwardly, to engage the item in position on the upright member(and reverse for removal). (62) Divided out of 520900
Patent NZ-537907-A (NZ)
Title: An upright surface treating appliance having a linkage between a surface treating head and handle
Inventor: COURTNEY STEPHEN BENJAMIN
IPC: A47L9/02
Filed: 2003-07-18
Abstract: A surface treating appliance 200, such as a vacuum cleaner, includes a handle 212, a surface treating head 230 and a support roller assembly 220. The support assembly is mounted to the main body 210 for allowing the main body to be rolled along a surface. A linkage 235 is provided between the main body and the surface treating head and arranged such that rotating the main body about its longitudinal axis 211 by twisting the handle 213 causes the surface treating head to turn in a new direction. The support assembly 220 may house a component of the appliance, such as a motor, and may accommodate a fluid inlet 531 for receiving fluid flow and a fluid outlet (535) for exhausting fluid. The handle may carry the main body 210 of the appliance.
Patent NZ-539707-A (NZ)
Title: Process for preparing 4-substituted 2,2,6,6-tetramethylpiperidin-N-oxy and 2,2,6,6-tetramethylpiperidin-N-hydroxy compounds
Inventor: OSTERHOLT CLEMENS
IPC: C07D211/94
Filed: 2005-04-29
Abstract: A process is described for preparing 4-substituted 2,2,6,6-tetramethylpiperidin-N-oxy compounds of the formula (II), or mixtures of (II) and 4-substituted 2,2,6,6-tetramethylpiperidin-N-hydroxy compounds represented by the formula (III). X and Y can be O, a cyclic ketal with radicals, or can represent an open-chain ketal in which X= O-R and Y= O-RÆ. The preparation process involves oxidizing 4-substituted 2,2,6,6-tetramethylpiperidines of the formula (I) by means of hydrogen peroxide in the presence of alkali metal hydrogencarbonate and/or ammonium hydrogencarbonate. The reaction is carried out with the addition of Bronsted acids with an acid strength greater than that of the hydrogencarbonate used.
Patent NZ-540564-A (NZ)
Title: Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
Inventor: CHALIFOUR ROBERT
IPC: C07K14/47
Filed: 2000-11-29
Abstract: Disclosed herein is a peptide that comprises the sequence of SEQ ID NO: 7, wherein amino acids of said SEQ ID NO: 7 consist entirely of [D]-amino acids. Also disclosed is the use of said peptide for the manufacture of a medicament for inducing an immune response against amyloid-beta in a mammal.
Patent NZ-545087-A (NZ)
Title: Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions
Inventor: KUTNEY JAMES P
IPC: A61P25/04
Filed: 2004-07-09
Abstract: Disclosed is a compound comprising a sterol or stanol, including biologically acceptable salts thereof, having one or more of the formulae a-f wherein R is a sterol or stanol moiety, R2 is a cholesterol biosynthesis inhibitor with at least one free and reactive carboxyl group; R3 is a cholesterol biosynthesis inhibitor with at least one free and reactive hydroxyl group; R4 is derived from ascorbic acid, X is either hydrogen or is selected from the group consisting of a biologically acceptable metal, or an alkali earth metal and n = 1-5, including all biologically acceptable salts or solvates thereof; wherein R is linked in formulae b), c), d) or f) via oxygen, R2 is linked in formulae b), c), d) or f) via a carboxyl function, and R3 is linked in formulae b), c), d) or f) via a hydroxyl group.
Patent NZ-545157-A (NZ)
Title: Isothiazoloquinolones and related compounds as anti-infective agents
Inventor: BRADBURY BARTON JAMES
IPC: C07D498/04
Filed: 2004-08-04
Abstract: The disclosure relates to compounds and salts of Formula (I) and Formula (II): which possess antimicrobial activity. The disclosure also relates to synthetic intermediates useful in making compounds of Formula (I) and Formula (II). The variables A1, R2, R3, R5, R6, R7, A8 and R9 are as defined in the specification. Certain compounds of Formula (I) and Formula (II) disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The disclosure also relates to antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula (I) or Formula (II) and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula (I) or Formula (II) as the only active agent or may contain a combination of a compound of Formula (I) or Formula (II) and one or more other active agents, wherein the compositions may be suitable for treating microbial infections in animals.
Patent NZ-547420-A (NZ)
Title: Cellulase (CELL) from ryegrass ( lolium ), nucleic acids encoding them and related methods, constructs and plants
Inventor: SPANGENBERG GERMAN
IPC: C12N15/82
Filed: 2001-09-28
Abstract: A substantially purified or isolated nucleic acid encoding cellulase (CELL) protein and its polypeptide from a ryegrass (Lolium) species are described. Vectors and plant cells comprising the nucleic acid are described. The nucleic acid can be introduced into a plant to modify lignin biosynthesis and/or cellulose degradation in a plant, or can be used as a molecular marker, for QTL tagging to mapping, DNA fingerprinting and marker assisted selections to for a herbage quality trait such as dry matter digestibility, mechanical stress tolerance, disease resistance, insect pest resistance, plant stature and leaf and stem colour.
Patent NZ-548013-A (NZ)
Title: Immunoglobulins
Inventor: ELLIS JONATHAN HENRY
IPC: C12N5/079
Filed: 2004-12-20
Abstract: Disclosed is an antibody which comprises each of the following CDRs: Light chain CDRs: SEQ.ID.NO: 1, 2 and 3 Heavy chain CDRs: SEQ.ID.NO: 4, 5 and 6, or a functional fragment or analogue thereof, wherein said antibody, functional fragment or analogue thereof binds to and neutralises human NOGO.
Patent NZ-551583-A (NZ)
Title: Prodrugs of pyrrolylpyrimidine ERK protein kinase inhibitors
Inventor: MARTINEZ-BOTELLA GABRIEL
IPC: A61P35/00
Filed: 2005-05-13
Abstract: Provided is the compound of Formula I-1, and similar specified compounds. Further provided is the use of such compounds in the manufacture of a medicament for the treatment of various diseases, including cancer, Alzheimer's disease and asthma.
Patent NZ-552196-A (NZ)
Title: Client processor device
Inventor: DONAGHEY ANDREW PAUL
IPC: G06F9/445
Filed: 2005-06-24
Abstract: A client processor device is disclosed. The device includes: a communications receiver for receiving file fragments for the device; a microcontroller system including a microcontroller and a programmable non-volatile memory system. The microcontroller system builds and stores application and data files from the fragments, and executes an application of the device by processing at least one application file and associated data identified by configuration instructions included in at least one of the fragments. The device stores application and data files for different versions of an application, and the configuration instructions select the versions for execution by the device.